Karyotyping is a test to examine chromosomes in a sample of cells. This test can help identify genetic problems as the cause of a disorder or disease.
How the Test is Performed
The test can be performed on almost any tissue, including:
- Amniotic fluid
- Bone marrow
- Tissue from the organ that develops during pregnancy to feed a growing baby (placenta)
To test amniotic fluid, an amniocentesis is done.
Amniocentesis is a test that can be done during pregnancy to look for these problems in the developing baby:Birth defectsGenetic problemsInfectionLun...Read Article Now Book Mark Article
A bone marrow biopsy is needed to take a sample of bone marrow.
Bone marrow biopsy
A bone marrow biopsy is the removal of marrow from inside bone. Bone marrow is the soft tissue inside bones that helps form blood cells. It is foun...Read Article Now Book Mark Article
The sample is placed into a special dish or tube and allowed to grow in the laboratory. Cells are later taken from the new sample and stained. The laboratory specialist uses a microscope to examine the size, shape, and number of chromosomes in the cell sample. The stained sample is photographed to show the arrangement of the chromosomes. This is called a karyotype.
Certain problems can be identified through the number or arrangement of the chromosomes. Chromosomes contain thousands of genes that are stored in DNA, the basic genetic material.
How to Prepare for the Test
Follow the health care provider's instructions on how to prepare for the test.
How the Test will Feel
How the test will feel depends on whether the sample procedure is having blood drawn (venipuncture), amniocentesis, or bone marrow biopsy.
Venipuncture is the collection of blood from a vein. It is most often done for laboratory testing.Read Article Now Book Mark Article
Why the Test is Performed
This test can:
- Count the number of chromosomes
- Look for structural changes in chromosomes
This test may be done:
- On a couple that has a history of miscarriage
- To examine any child or baby who has unusual features or developmental delays
The bone marrow or blood test can be done to identify the Philadelphia chromosome, which is found in 85% of people with chronic myelogenous leukemia (CML).
Chronic myelogenous leukemia (CML)
Chronic myelogenous leukemia (CML) is cancer that starts inside bone marrow. This is the soft tissue in the center of bones that helps form all bloo...Read Article Now Book Mark Article
The amniotic fluid test is done to check a developing baby for chromosome problems.
Your provider may order other tests that go together with a karyotype:
- Microarray: Looks at small changes in the chromosomes
- Fluorescent in situ hybridization (FISH): Looks for small mistakes such as deletions in the chromosomes
Normal results are:
- Females: 44 autosomes and 2 sex chromosomes (XX), written as 46, XX
- Males: 44 autosomes and 2 sex chromosomes (XY), written as 46, XY
What Abnormal Results Mean
Abnormal results may be due to a genetic syndrome or condition, such as:
Chemotherapy may cause chromosome breaks that affect normal karyotyping results.
Risks are related to the procedure used to obtain the sample.
In some cases, a problem may occur to the cells growing in the lab dish. Karyotype tests should be repeated to confirm that an abnormal chromosome problem is actually in the body of the person.
Bacino CA, Lee B. Cytogenetics. In: Kliegman RM, Stanton BF, St. Geme JW, Schor NF, eds. Nelson Textbook of Pediatrics. 20th ed. Philadelphia, PA: Elsevier; 2016:chap 81.
Stein CK. Applications of cytogenetics in modern pathology. In: McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. 23rd ed. St Louis, MO: Elsevier; 2017:chap 69.
Karyotyping - illustration
Karyotyping is a test used to identify chromosome abnormalities as the cause of malformation or disease. The test can be performed on a sample of blood, bone marrow, amniotic fluid, or placental tissue.
Review Date: 10/15/2018
Reviewed By: Anna C. Edens Hurst, MD, MS, Assistant Professor in Medical Genetics, The University of Alabama at Birmingham, Birmingham, AL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.